Apyx Medical Corp
APYXNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $52.8M | $48.1M | $52.3M | $44.5M | $48.5M | $27.7M |
| Operating income | −$6.4M | −$18.8M | −$17.3M | −$23.6M | −$14.4M | −$20.1M |
| Net income | −$11.2M | −$23.5M | −$18.7M | −$23.2M | −$15.2M | −$11.9M |
| Total assets | $66.8M | $64.8M | $79.2M | $51.8M | $68.7M | $74.1M |
| Total liabilities | $52.0M | $50.5M | $52.3M | $14.0M | $14.7M | $10.3M |
| Equity | $14.5M | $14.2M | $26.7M | $37.6M | $53.7M | $63.7M |
| EPS (diluted) | $-0.27 | $-0.66 | $-0.54 | $-0.67 | $-0.44 | $-0.35 |
| Shares out. | 37.8M | 34.6M | 34.6M | 34.4M | 34.3M | 34.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −12.2%
- Net margin
- −21.2%
- Return on equity
- −77.1%
- Return on assets
- −16.8%
- Return on capital (ROCE)
- −11.7%
- Liabilities / assets
- 77.8%
- Debt / equity
- 3.58×
- Book value / share
- $0.38
- Revenue growth (YoY)
- 9.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -0.11distress
- Accruals / assets
- −4.8%clean
- Beneish M-Score
- -2.63normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 16, 2020
- NT 10-Qmissed a reporting deadline ↗Nov 13, 2019
- NT 10-Qmissed a reporting deadline ↗Aug 16, 2005
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2001
- NT 10-Qmissed a reporting deadline ↗May 15, 2001
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2000
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Nantahala Capital Management, LlcPassive (13G)Feb 13, 2026
- Royce & Associates LpPassive (13G)Jan 20, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 167,446 | 1.0 | -24.3% |
| Apr 30, 2026 | 221,167 | 2.0 | +12.9% |
| Apr 15, 2026 | 195,810 | 1.6 | +1.6% |
| Mar 31, 2026 | 192,757 | 1.4 | +16.9% |
| Mar 13, 2026 | 164,872 | 1.0 | -5.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 21, 2026
- Other material eventMay 14, 2026
- Other material eventMay 11, 2026
- Results of operationsMay 7, 2026
- Results of operationsMar 10, 2026
- Results of operationsJan 12, 2026
- Amended charter or bylawsDec 12, 2025
- Entered a material agreement · Other material eventNov 19, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SDFORM SDJun 1, 2026
- 8-KFORM 8-KMay 21, 2026
- 8-KFORM 8-KMay 14, 2026
- 8-KFORM 8-KMay 11, 2026
- 10-QFORM 10-QMay 7, 2026
- 8-KFORM 8-KMay 7, 2026
- 4Mar 17, 2026
- 10-KFORM 10-KMar 10, 2026
- 8-KFORM 8-KMar 10, 2026
- SCHEDULE 13G/AFeb 13, 2026
- 4Jan 29, 2026
- SCHEDULE 13G/AJan 20, 2026
- 8-KFORM 8-KJan 12, 2026
- EFFECTDec 16, 2025
- 8-KDec 12, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.